These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33139926)

  • 1. The SARS-CoV-2 spike protein: balancing stability and infectivity.
    Berger I; Schaffitzel C
    Cell Res; 2020 Dec; 30(12):1059-1060. PubMed ID: 33139926
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.
    Yan R; Zhang Y; Li Y; Ye F; Guo Y; Xia L; Zhong X; Chi X; Zhou Q
    Cell Res; 2021 Jun; 31(6):717-719. PubMed ID: 33737693
    [No Abstract]   [Full Text] [Related]  

  • 3. The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.
    Liu H; Zhang Q; Wei P; Chen Z; Aviszus K; Yang J; Downing W; Jiang C; Liang B; Reynoso L; Downey GP; Frankel SK; Kappler J; Marrack P; Zhang G
    Cell Res; 2021 Jun; 31(6):720-722. PubMed ID: 33893398
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants.
    Upadhyay V; Lucas A; Panja S; Miyauchi R; Mallela KMG
    J Biol Chem; 2021 Oct; 297(4):101208. PubMed ID: 34543625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants' spike protein-an in silico analysis.
    Pokhrel S; Kraemer BR; Lee L; Samardzic K; Mochly-Rosen D
    PLoS One; 2021; 16(5):e0251426. PubMed ID: 34038453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.
    Wrobel AG; Benton DJ; Xu P; Calder LJ; Borg A; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Commun; 2021 Feb; 12(1):837. PubMed ID: 33547281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif.
    Lorenzo R; Defelipe LA; Aliperti L; Niebling S; Custódio TF; Löw C; Schwarz JJ; Remans K; Craig PO; Otero LH; Klinke S; García-Alai M; Sánchez IE; Alonso LG
    J Biol Chem; 2021 Oct; 297(4):101175. PubMed ID: 34499924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.
    Rattanapisit K; Bulaon CJI; Khorattanakulchai N; Shanmugaraj B; Wangkanont K; Phoolcharoen W
    PLoS One; 2021; 16(8):e0253574. PubMed ID: 34379620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants.
    Du S; Liu P; Zhang Z; Xiao T; Yasimayi A; Huang W; Wang Y; Cao Y; Xie XS; Xiao J
    Cell Res; 2021 Oct; 31(10):1130-1133. PubMed ID: 34433900
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability.
    Moss DL; Rappaport J
    J Biol Chem; 2021 Dec; 297(6):101371. PubMed ID: 34756892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
    Zhu X; Mannar D; Srivastava SS; Berezuk AM; Demers JP; Saville JW; Leopold K; Li W; Dimitrov DS; Tuttle KS; Zhou S; Chittori S; Subramaniam S
    PLoS Biol; 2021 Apr; 19(4):e3001237. PubMed ID: 33914735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of novel combinations of SARS-CoV-2 spike receptor binding domain variants in Senegal.
    Ahouidi AD; Rodgers MA; Padane A; Leye N; Olivo A; Mbow M; Mboup A; Diaw PA; Dia A; Harris B; Padane YAD; Lo G; Meyer TV; Diedhiou CK; Diagne D; Kane NCT; Cloherty G; Mboup S
    Sci Rep; 2021 Dec; 11(1):23644. PubMed ID: 34880295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 first contact: Spike-ACE2 interactions in COVID-19.
    Nesci S
    Chem Biol Drug Des; 2021 Aug; 98(2):207-211. PubMed ID: 34047452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry.
    Wang D; Zhou B; Keppel TR; Solano M; Baudys J; Goldstein J; Finn MG; Fan X; Chapman AP; Bundy JL; Woolfitt AR; Osman SH; Pirkle JL; Wentworth DE; Barr JR
    Sci Rep; 2021 Dec; 11(1):23561. PubMed ID: 34876606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America.
    Wang R; Chen J; Wei GW
    J Phys Chem Lett; 2021 Dec; 12(49):11850-11857. PubMed ID: 34873910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants.
    Xu H; Wang B; Zhao TN; Liang ZT; Peng TB; Song XH; Wu JJ; Wang YC; Su XD
    Cell Res; 2021 Oct; 31(10):1126-1129. PubMed ID: 34480123
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape.
    Yang L; Li J; Guo S; Hou C; Liao C; Shi L; Ma X; Jiang S; Zheng B; Fang Y; Ye L; He X
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.